Home › Islet Cell Adenoma
Islet Cell Adenoma clinical trials recruiting in the U.S.
11 studies for Islet Cell Adenoma are recruiting participants at sites across the United States.
Cities with the most studies
- Los Angeles, CA6 studies
- Rochester, MN5 studies
- Washington, DC4 studies
- Phoenix, AZ4 studies
- Portland, OR4 studies
- St. Louis, MO4 studies
- Chicago, IL4 studies
- Nashville, TN3 studies
- Boston, MA3 studies
- Lexington, KY3 studies
- Columbus, OH3 studies
- Philadelphia, PA3 studies
- Salt Lake City, UT3 studies
- Jacksonville, FL3 studies
By state
- Arizona4 studies
- California7 studies
- Florida4 studies
- Illinois5 studies
- Iowa3 studies
- Kentucky3 studies
- Maryland4 studies
- Massachusetts3 studies
- Michigan3 studies
- Minnesota5 studies
- Missouri4 studies
- New York3 studies
- Ohio4 studies
- Oregon4 studies
- Pennsylvania3 studies
- Tennessee4 studies
- Texas3 studies
- Utah3 studies
- Virginia3 studies
Recently updated studies
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Nov 13, 2026 · NCT04924075Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07165132Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06943755Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT05687123A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992Nutrition Intervention for Pancreatic Cancer
Recruiting
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT07554560Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 9, 2026 · NCT00830557Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 26, 2026 · NCT05746182Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT06663072Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT05040360From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.